Unknown

Dataset Information

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhil-15) is associated with robust expansion of peripheral blood CD56+ NK cells


ABSTRACT:

SUBMITTER: Morishima C 

PROVIDER: S-EPMC4288749 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature